4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001725663-25-000004
Chief Financial Officer sold 8,910 shares at $9.98 ($88,932)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WENTWORTH KORY JAMES · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-21 | Sale : show line 1 in the form 10b5-1 | −8,910 | $9.98 | $88,932 | 110,026 | D |
| Open-market sales · 8,910 sh · avg $9.98 · $88,932 | ||||||
Loading xslF345X05/wk-form4_1764019838.xml…